reports
- James Ratzer
Cellnex vs. Telefonica Cellnex (Buy, €34, +32%) Telefonica (Reduce, ...
On Wednesday, we published our European Telecoms Year Ahead note for 2026. In that note, we upgraded Cellnex to a Buy, as we think the market’s worst fears on growth are overdone, and we downgraded Telefonica to a Reduce, as we fear the low cashflow growth outlook is not being properly priced in. However, in that sector report, we missed out one important aspect to back up this diverging view of value and we now highlight that here.
- Ben Rickett
- James Ratzer
- Russell Waller
Cellnex (Buy, €34, +34%) Inwit (Buy, €11.8, +56%) Both upgraded to BU...
Yesterday, we published our sector lookahead for EU telecoms names for 2026. There is a lot of material in the report, but as part of the review, we upgraded Cellnex and Inwit to Buy for the first time since 2017 and 2023 respectively.
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...
Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...
- Research Department
IBERIAN DAILY 12 DECEMBER (ANÁLISIS BANCO SABADELL)
NEWS SUMMARY: CELLNEX, FERROVIAL, GRUPO SANJOSE, REPSOL, TELEFÓNICA, VIDRALA. The Ibex near 17,000 points European stock markets climbed near 1% yesterday after the Fed’s rate cut and despite doubts surrounding the technology sector after the poor reception of Oracle’s results. In the STOXX 600, Construction (that rallied after being the worst-performing sector last Wednesday) and Leisure, closely followed by Banks led the gains whereas Utilities and Energy were almost the only sectors ending w...
- Research Department
INFORME DIARIO 12 DICIEMBRE (ANÁLISIS BANCO SABADELL)
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CELLNEX, FERROVIAL, GRUPO SANJOSE, REPSOL, TELEFÓNICA, VIDRALA. EUROPA: BNP PARIBAS. El Ibex enfila los 17.000 puntos Las bolsas europeas avanzaron ayer cerca de un 1% tras la bajada de tipos por parte de la Fed y pese a las dudas en las tecnológicas tras la mala acogida de los resultados de Oracle. En el STOXX 600, los mejores sectores fueron Construcción (rebotó tras ser el miércoles el peor sector) y Ocio seguido de cerca por los Bancos mientras...
Philips reiterates timing of 2026 outlook
Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...
Moody's Ratings assigns Ba2 instrument rating to Almirall's proposed s...
Moody's Ratings (Moody's) has today assigned a Ba2 instrument rating to the proposed €250 million backed senior unsecured notes due 2031 to be issued by Almirall, S.A. (Almirall or the company). The outlook is unchanged at stable. Proceeds from the issuance of the backed senior unsecured notes as ...
Philips expands commercial availability of world’s first real-time AI-...
Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...
Philips launches Verida, world’s first detector-based spectral CT powe...
Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...
Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...
Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...
Philips launches next-generation web-based diagnostic viewer for fast,...
Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere November 24, 2025 New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, [1] that transforms how radiologists access and interpret medical images. Designed with a brand-new user interface, the viewe...
Philips and Cortechs.ai extend partnership to advance quantitative neu...
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology November 19, 2025Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership with , a pioneer in quantitative neuroimaging solutions. Together, the companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems [1], empowering clinicians with faster, more objective, and reproducible insights into brain health. The col...
- Marc Hesselink
- CFA
- Thymen Rundberg
Philips/Something better, something worse/HOLD
Philips reported a better-than-expected 3Q25 update although with mixed underlying quality. We have limited changes to estimates and reiterate our €23/share target price and Hold rating. We believe valuation is fair relative to peers given Philips' lower growth and margin profile.
Philips brings AI into the procedure room to assist doctors during hea...
Philips brings AI into the procedure room to assist doctors during heart valve repair November 17, 2025Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence**Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one of interventional cardiology’s most technically demanding procedures: repairing leaking heart valves through a minimally invasive appr...
- Martin Marandon-Carlhian
- Sinan Doganli
- Usama Tariq
- Martin Marandon-Carlhian
- Sinan Doganli
- Usama Tariq
- Juan Ros-Padilla
- Luis Arredondo
- Luis Arredondo
ALMIRALL: 3Q’25 RESULTS (ANÁLISIS BANCO SABADELL)
3Q'25 vs. 3Q'24 Results Sales: € 260.2 M (+12.9% vs. +12.3% BS(e) and +13.1% consensus); EBITDA: € 58.9 M (+56.2% vs. +39.4% BS(e) and +41.1% consensus); EBIT: € 22.0 M (+746.2% vs. +405.8% BS(e) and +519.2% consensus); Net Profit: € 10.7 M (€ -5.5 M in 3Q’24 vs. € 5.91 M BS(e) and € 6.0 M consensus); 9M'25 vs. 9M'24 Results Sales: € 820.7 M (+12.8% vs. +12.6% BS(e) and +12.8% consensus); EBITDA: € 180.7 M (+27.1% vs. +22.6% BS(e) and +23.1% consensus); EBIT: € 67.4 M (+75.1% vs. +52.1% BS(e) an...
- Luis Arredondo
ALMIRALL: RDOS. 3T’25 (ANÁLISIS BANCO SABADELL)
Rdos. 3T'25 vs 3T'24: Ventas: 260,2 M euros (+12,9% vs +12,3% BS(e) y +13,1% consenso); EBITDA: 58,9 M euros (+56,2% vs +39,4% BS(e) y +41,1% consenso); EBIT: 22,0 M euros (+746,2% vs +405,8% BS(e) y +519,2% consenso); BDI: 10,7 M euros (-5,5 M euros en 9meses'24 vs 5,91 M euros BS(e) y 6,0 M euros consenso); Rdos. 9meses'25 vs 9meses'24: Ventas: 820,7 M euros (+12,8% vs +12,6% BS(e) y +12,8% consenso); EBITDA: 180,7 M euros (+27,1% vs +22,6% BS(e) y +23,1% consenso); EBIT: 67,4 M euros (+75,1% ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.